RLAY:US
$3.74
1.63%
Relay Therapeutics Inc.News & Events
Last updated: Jul 28, 2025, 8:09 AM ET
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology
Canada Newswire JUN 20, 2025 9:21 AM EDTWith Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology ...READ ARTICLEWith Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology
PR Newswire JUN 20, 2025 9:21 AM EDTWith Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology ...READ ARTICLERelay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
GlobeNewswire JUN 11, 2025 4:05 PM EDTCAMBRIDGE, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), ...READ ARTICLERelay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025
GlobeNewswire JUN 2, 2025 7:00 AM EDTUpdated interim data remain consistent, showing 10.3-month median PFS overall and 11.0-month medi...READ ARTICLERelay Therapeutics to Participate in Two Upcoming Investor Conferences in June
GlobeNewswire MAY 29, 2025 4:05 PM EDTCAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a...READ ARTICLEHealthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders
Canada Newswire MAY 27, 2025 9:45 AM EDTHealthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders Canada NewsWi...READ ARTICLEHealthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders
PR Newswire MAY 27, 2025 9:45 AM EDTHealthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders PR Newswire ...READ ARTICLERelay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates
GlobeNewswire MAY 5, 2025 4:05 PM EDTCash runway extended into 2029 Initiation of Phase 3 ReDiscover-2 trial on tr...READ ARTICLERelay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025
GlobeNewswire APR 28, 2025 4:05 PM EDTCAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY),...READ ARTICLERelay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
GlobeNewswire FEB 26, 2025 4:05 PM ESTInitiation of Phase 3 ReDiscover-2 trial of RLY-2608 + fulves...READ ARTICLE